Karma is solving autoimmunity using Xavines to specifically switch off only the patient's rogue immune cells instead of their entire immune system.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free